Objective: To deeply explore the clinical value of combined detection of serum homocysteine (Hcy) and uric acid (UA) in hypertensive patients. Methods: A total of 63 hypertensive patients admitted to the Third People’s Hospital of Nanning from January 1, 2022, to December 31, 2023, were selected as the hypertensive group, and 63 healthy subjects during the same period were selected as the healthy group. Serum Hcy and UA were detected in both groups. The detection levels were compared between the two groups, and the differences in serum Hcy and UA levels among hypertensive patients at different grades in the hypertensive group were analyzed. Results: The levels of Hcy and UA in the healthy group were significantly lower than those in the hypertensive group (P < 0.05). In the hypertensive group, the serum Hcy and UA levels of patients with grade 3 hypertension were significantly higher than those of patients with grade 1 and grade 2 hypertension, and with the increase of hypertension grade, the levels of these two indicators also increased (P < 0.05). Conclusion: The combined detection of serum Hcy and UA in hypertensive patients can effectively distinguish hypertensive patients from healthy people, assist in evaluating the severity of hypertension, and provide important clinical evidence for the prevention, evaluation of the condition, and subsequent treatment of hypertension.
KeywordsHypertensionSerum HomocysteineUric AcidCombined DetectionClinical Value
Shi, Y.X. (2015) Introduction to Professor Li Ying’s Experience in Treating Hypertensive Nephropathy. Electronic Journal of Cardiovascular Diseases Integrated Traditional Chinese and Western Medicine , No. 16, 75-76.
Feng, S.S., Sun, C.J. and Shi, X.M. (2020) Influence of the “Activating Blood and Dispelling Wind” Acupuncture Method on Blood Lipids and Morning Blood Pressure in Patients with Hypertensive Stroke of Phlegm-Blood Sta-sis Type. Jilin Journal of Traditional Chinese Medicine , 40, 394-397.
Yao, X., Pei, X.T. and Qu, Z. (2022) Study on the Changing Trends and Influencing Factors of the Prevalence, Awareness Rate, Treatment Rate, and Control Rate of Hypertension among Chinese Adults from 1991 to 2015. Chinese General Practice , 25, 803-814.
Yu, P., Ning, Y., Gao, Y., Zhao, Y., Tie, L., Wu, L., et al . (2021) Hypertension among Mongolian Adults in China: A Cross‐Sectional Study of Prevalence, Awareness, Treatment, Control, and Related Factors: Hypertension among Mongolian Adults in China. The Journal of Clinical Hypertension , 23, 1786-1801. https://doi.org/10.1111/jch.14348
Hypertension Branch of Chinese Geriatrics Society, Chinese Geriatric Cardiovascular Disease Prevention and Treatment Alliance of National Clinical Research Center for Geriatric Diseases (2019) Chinese Guidelines for the Management of Hypertension in the Elderly 2019. Chinese Journal of Cardiovascular Diseases , 24, 1-23.
Zhang, H., Cai, R., Qi, H.Y., et al . (2020) Relationship between Serum Cystatin C, Homocysteine Levels and Target Organ Damage in Patients with Essential Hypertension. Journal of Clinical and Experimental Medicine , 19, 363-366.
Zhang, J., Guo, Q., Peng, L., Li, J., Gao, Y., Yan, B., et al . (2018) The Association of Neck Circumference with Incident Congestive Heart Failure and Coronary Heart Disease Mortality in a Community-Based Population with or without Sleep-Disordered Breathing. BMC Cardiovascular Disorders , 18, Article No. 108. https://doi.org/10.1186/s12872-018-0846-9
Feng, W.H., Zhan, Q.Z., Zhang, Y.F. (2020) Significance of Detecting Homocysteine (Hcy) in Patients with Essential Hypertension for Judging the Condition of Hypertension. Electronic Journal of Clinical Medical Literature , 7, 73, 86.
Chen, T. (2021) Clinical Value of Combined Detection of Serum Cystatin C and Homocysteine in the Diagnosis of Early Nephropathy in Hypertension. China Practical Medicine , 16, 14-16.
Wang, J. (2022) Clinical Significance of Combined Detection of Serum Homocysteine and Uric Acid in the Diagnosis of Essential Hypertension. Marriage , Reproduction and Health , 28, 131-133.
Li, Y., Li, B., Sun, J.X., et al . (2019) Correlation Analysis between Serum Uric Acid and Risk Factors of Cardiovascular Diseases in Aircrew. Journal of Air Force Medicine , 35, 203-205.
Wen, F.M., Yan, J.Y., Zhang, Y.M., et al . (2010) Relationship between Serum D-Dimer, Homocysteine and Uric Acid Contents and Hypertension. Journal of Cardiovascular Rehabilitation Medicine , 19, 242-244.
Wang, R., Meng, W. and Jiang, J.J. (2019) Study on the Significance of Detecting Homocysteine in Patients with Essential Hypertension. Chinese and Foreign Medical Research , 17, 69-70.
Xie, X., Atkins, E., Lv, J., Bennett, A., Neal, B., Ninomiya, T., et al . (2016) Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: Updated Systematic Review and Meta-Analysis. The Lancet , 387, 435-443. https://doi.org/10.1016/s0140-6736(15)00805-3
Li, Y., Zhang, M., Zhang, X., et al . (2017) Association between Serum Uric Acid Levels and Hypertension: A Meta-Analysis of Observational Studies. International Journal of Cardiology , 228, 842-849.
Duan, X., Liu, X., Liu, Y., et al . (2018) Association between Plasma Homocysteine Levels and Hypertension: A Meta-Analysis of Observational Studies. Clinica Chimica Acta , 486, 326-333.
World Medical Association (2013) World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA , 310, 2191-2194.
Chinese Hypertension Prevention and Treatment Guideline Revision Committee (2019) Revised Chinese Guidelines for the Prevention and Treatment of Hypertension 2018. Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases , 19, 1-44.
Mundt, C., Dugas, M. and Gawaz, M. (2015) Pre-Analytical Variables in Coagulation Testing: A Practical Guide. Thrombosis and Haemostasis , 113, 661-673.
Clinical and Laboratory Standards Institute (2017) Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests; Approved Guideline-Fifth Edition. CLSI Document H21-A5. Clinical and Laboratory Standards Institute.
Krause, T., Connelly, J., Risch, L., et al . (2014) The Use of Homocysteine and Cystatin C for Prediction of Cardiovascular Events: A Systematic Review and Meta-Analysis. Annals of Internal Medicine , 160, 600-609.
Armitage, P., Berry, G. and Matthews, J.N.S. (2002) Statistical Methods in Medical Research. 4th Edition, Wiley. https://doi.org/10.1002/9780470773666
Chobanian, A.V., Bakris, G.L., Black, H.R., et al . (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure the JNC 7 Report. JAMA , 289, 2560-2572. https://doi.org/10.1001/jama.289.19.2560
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., et al . (2013) 2013 ESH/ESC Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension , 31, 1281-1357. https://doi.org/10.1097/01.hjh.0000431740.32696.cc
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., et al . (2018) 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension. European Heart Journal , 39, 3021-3104. https://doi.org/10.1093/eurheartj/ehy339
Lloyd-Jones, D.M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L.J., Van Horn, L., et al . (2010) Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association’s Strategic Impact Goal through 2020 and Beyond. Circulation , 121, 586-613. https://doi.org/10.1161/circulationaha.109.192703
Vasan, R.S., Beiser, A., Seshadri, S., Larson, M.G., Kannel, W.B., D’Agostino, R.B., et al . (2002) Residual Lifetime Risk for Developing Hypertension in Middle-Aged Women and Men: the Framingham Heart Study. JAMA , 287, 1003-1010. https://doi.org/10.1001/jama.287.8.1003
Lewington, S., Clarke, R., Qizilbash, N., et al . (2002) Age-Specific Relevance of Usual Blood Pressure to Vascular Mortality: A Meta-Analysis of Individual Data for One Million Adults in 61 Prospective Studies. The Lancet , 360, 1903-1913.
Lawes, C.M., Hoorn, S.V. and Rodgers, A. (2008) Global Burden of Blood-Pressure-Related Disease, 2001. The Lancet , 371, 1513-1518. https://doi.org/10.1016/s0140-6736(08)60655-8
He, J., Gu, D., Wu, X., Reynolds, K., Duan, X., Yao, C., et al . (2005) Major Causes of Death among Men and Women in China. New England Journal of Medicine , 353, 1124-1134. https://doi.org/10.1056/nejmsa050467
Boushey, C.J., Beresford, S.A., Omenn, G.S., et al . (1995) A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease. Probable Benefits of Increasing Folic Acid Intakes. JAMA , 274, 1049-1057. https://doi.org/10.1001/jama.1995.03530130055028
Welch, G.N. and Loscalzo, J. (1998) Homocysteine and Atherothrombosis. New England Journal of Medicine , 338, 1042-1050. https://doi.org/10.1056/nejm199804093381507
Clarke, R., Halsey, J., Lewington, S., et al . (2010) Effects of Lowering Homocysteine Levels with B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific Mortality: Meta-Analysis of 8 Randomized Trials Involving 37,485 Individuals. Archives of Internal Medicine , 170, 1622-1631.
Lentz, S.R., Furie, B.C., Furie, B., et al . (1996) Homocysteine-Induced Activation of the Blood Coagulation Pathway in Normal Subjects: A Possible Mechanism for Thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology , 16, 1281-1288.
Loscalzo, J. (1996) Homocysteine and Thrombosis. Blood , 88, 2848-2860.
Refsum, H., Ueland, P.M., Nygård, O., et al . (2006) Homocysteine and Cardiovascular Disease. Annual Review of Medicine , 57, 373-388.
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M.A., Oleggini, M., Graziadei, L., et al . (1987) Insulin Resistance in Essential Hypertension. New England Journal of Medicine , 317, 350-357. https://doi.org/10.1056/nejm198708063170605
Reaven, G.M. (1988) Role of Insulin Resistance in Human Disease. Diabetes , 37, 1595-1607. https://doi.org/10.2337/diab.37.12.1595
Facchini, F.S., Chen, Y.D., Hollenbeck, C.B., et al . (1991) Relationship between Insulin Resistance, Hyperinsulinemia, and Hyperuricemia in Nondiabetic Individuals. Journal of Laboratory and Clinical Medicine , 118, 216-220.
Feig, D.I., Kang, D. and Johnson, R.J. (2008) Uric Acid and Cardiovascular Risk. New England Journal of Medicine , 359, 1811-1821. https://doi.org/10.1056/nejmra0800885
Kanbay, M., Afsar, B., Turgut, F., et al . (2012) Uric Acid and Hypertension. Current Hypertension Reports , 14, 335-342.
Johnson, R.J., Segal, M.S., Sautin, Y., et al . (2007) Potential Role of Uric Acid in Causing the Metabolic Syndrome and Hypertension. Current Hypertension Reports , 9, 17-23.
Kang, D.H., Park, S.K., Lee, I.K., et al . (2005) Hyperuricemia Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism. Hypertension , 45, 102-107.
Sautin, Y.Y. and Johnson, R.J. (2007) The Role of Uric Acid in Hypertension and the Metabolic Syndrome. Current Hypertension Reports , 9, 165-170.
Nakagawa, T., Hu, H., Zharikov, S., Tuttle, K.R., Short, R.A., Glushakova, O., et al . (2006) A Causal Role for Uric Acid in Fructose-Induced Metabolic Syndrome. American Journal of Physiology-Renal Physiology , 290, F625-F631. https://doi.org/10.1152/ajprenal.00140.2005